Q2 2019 Earnings Forecast for Smith & Nephew plc Issued By Northcoast Research (SNN)

Smith & Nephew plc (NYSE:SNN) – Equities research analysts at Northcoast Research decreased their Q2 2019 earnings per share (EPS) estimates for Smith & Nephew in a note issued to investors on Monday, April 16th. Northcoast Research analyst D. Keiser now forecasts that the medical equipment provider will post earnings per share of $0.99 for the quarter, down from their previous forecast of $1.00. Northcoast Research also issued estimates for Smith & Nephew’s Q4 2019 earnings at $1.08 EPS and FY2019 earnings at $2.07 EPS.

How to Become a New Pot Stock Millionaire

Other research analysts have also recently issued reports about the company. Canaccord Genuity reissued a “buy” rating on shares of Smith & Nephew in a research report on Thursday, February 8th. Zacks Investment Research raised Smith & Nephew from a “hold” rating to a “buy” rating and set a $43.00 price target for the company in a research report on Wednesday, March 28th. HSBC raised Smith & Nephew from a “hold” rating to a “buy” rating in a research report on Monday, March 26th. ValuEngine cut Smith & Nephew from a “buy” rating to a “hold” rating in a research report on Friday, February 9th. Finally, JPMorgan Chase raised Smith & Nephew from a “neutral” rating to an “overweight” rating in a research report on Thursday, January 25th. Two analysts have rated the stock with a hold rating and five have given a buy rating to the company. Smith & Nephew presently has an average rating of “Buy” and an average price target of $43.50.

Shares of NYSE SNN opened at $38.16 on Tuesday. Smith & Nephew has a 52 week low of $31.77 and a 52 week high of $40.43. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.06 and a current ratio of 2.03.

The firm also recently disclosed a None dividend, which will be paid on Wednesday, May 9th. Stockholders of record on Friday, April 6th will be given a $0.444 dividend. The ex-dividend date of this dividend is Thursday, April 5th. Smith & Nephew’s payout ratio is 35.79%.

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Icon Wealth Partners LLC acquired a new stake in shares of Smith & Nephew in the fourth quarter valued at approximately $120,000. SeaCrest Wealth Management LLC acquired a new stake in shares of Smith & Nephew in the fourth quarter valued at approximately $121,000. Steward Partners Investment Advisory LLC acquired a new stake in shares of Smith & Nephew in the fourth quarter valued at approximately $126,000. Avestar Capital LLC acquired a new stake in shares of Smith & Nephew in the fourth quarter valued at approximately $160,000. Finally, Premia Global Advisors LLC acquired a new stake in shares of Smith & Nephew in the fourth quarter valued at approximately $214,000. 6.89% of the stock is owned by institutional investors.

ILLEGAL ACTIVITY NOTICE: This piece of content was originally reported by Chaffey Breeze and is the sole property of of Chaffey Breeze. If you are accessing this piece of content on another site, it was illegally stolen and republished in violation of U.S. and international trademark and copyright laws. The legal version of this piece of content can be viewed at https://www.chaffeybreeze.com/2018/04/17/q2-2019-earnings-forecast-for-smith-nephew-plc-issued-by-northcoast-research-snn.html.

Smith & Nephew Company Profile

Smith & Nephew plc is a medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. Its products and services include Sports Medicine Joint Repair, Arthroscopic Enabling Technologies (AET), Trauma & Extremities, Other Surgical Businesses, Knee Implants, Hip Implants, Advanced Wound Care, Advanced Wound Bioactives and Advanced Wound Devices.

Earnings History and Estimates for Smith & Nephew (NYSE:SNN)

Receive News & Ratings for Smith & Nephew Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply